The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)

BACKGROUND: It is frequently asked whether chemotherapy can still play a role in metastatic melanoma considering the effectiveness of the available drugs today, including antiCTLA4/antiPD1 immunotherapy and antiBRAF/antiMEK inhibitors. However, only approximately half of patients respond to these dr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Cancer
Hauptverfasser: Guida, Michele, Tommasi, Stefania, Strippoli, Sabino, Natalicchio, Maria Iole, De Summa, Simona, Pinto, Rosamaria, Cramarossa, Antonio, Albano, Anna, Pisconti, Salvatore, Aieta, Michele, Ridolfi, Ruggiero, Azzariti, Amalia, Guida, Gabriella, Lorusso, Vito, Colucci, Giusepe
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2018
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946485/
https://ncbi.nlm.nih.gov/pubmed/29747595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4479-2
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge